215 related articles for article (PubMed ID: 22155797)
1. A study of symptoms described by ovarian cancer survivors.
Stavraka C; Ford A; Ghaem-Maghami S; Crook T; Agarwal R; Gabra H; Blagden S
Gynecol Oncol; 2012 Apr; 125(1):59-64. PubMed ID: 22155797
[TBL] [Abstract][Full Text] [Related]
2. Self-reported distress in patients with ovarian cancer: is it related to disease status?
Ploos van Amstel FK; van Ham MA; Peters EJ; Prins JB; Ottevanger PB
Int J Gynecol Cancer; 2015 Feb; 25(2):229-35. PubMed ID: 25594140
[TBL] [Abstract][Full Text] [Related]
3. Determinants of quality of life in ovarian cancer survivors: a pilot study.
Teng FF; Kalloger SE; Brotto L; McAlpine JN
J Obstet Gynaecol Can; 2014 Aug; 36(8):708-715. PubMed ID: 25222166
[TBL] [Abstract][Full Text] [Related]
4. Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study.
Friedlander ML; Stockler M; O'Connell R; Voysey M; Oza A; Gillies K; Donovan H; Martyn J; Sjoquist K; Butow P; King MT;
Int J Gynecol Cancer; 2014 Jun; 24(5):857-64. PubMed ID: 24844219
[TBL] [Abstract][Full Text] [Related]
5. Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones?
Liavaag AH; Dørum A; Fosså SD; Tropé C; Dahl AA
J Clin Oncol; 2007 May; 25(15):2049-56. PubMed ID: 17513809
[TBL] [Abstract][Full Text] [Related]
6. Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
Joly F; Ahmed-Lecheheb D; Kalbacher E; Heutte N; Clarisse B; Grellard JM; Gernier F; Berton-Rigaud D; Tredan O; Fabbro M; Savoye AM; Kurtz JE; Alexandre J; Follana P; Delecroix V; Dohollou N; Roemer-Becuwe C; De Rauglaudre G; Lortholary A; Prulhiere K; Lesoin A; Zannetti A; N'Guyen S; Trager-Maury S; Chauvenet L; Abadie Lacourtoisie S; Gompel A; Lhommé C; Floquet A; Pautier P
Ann Oncol; 2019 May; 30(5):845-852. PubMed ID: 30851097
[TBL] [Abstract][Full Text] [Related]
7. Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients.
Brown AJ; Sun CC; Urbauer DL; Bodurka DC; Thaker PH; Ramondetta LM
Gynecol Oncol; 2015 Aug; 138(2):388-93. PubMed ID: 25988961
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women.
Kim SI; Lee Y; Lim MC; Joo J; Park K; Lee DO; Park SY
J Gynecol Oncol; 2015 Apr; 26(2):148-54. PubMed ID: 25686396
[TBL] [Abstract][Full Text] [Related]
9. Presence of gastro-intestinal symptoms in ovarian cancer patients during survivorship: a cross-sectional study from the PROFILES registry.
Rietveld MJA; Husson O; Vos MCC; van de Poll-Franse LV; Ottevanger PBN; Ezendam NPM
Support Care Cancer; 2019 Jun; 27(6):2285-2293. PubMed ID: 30328539
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
11. OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.
Webber K; Carolus E; Mileshkin L; Sommeijer D; McAlpine J; Bladgen S; Coleman RL; Herzog TJ; Sehouli J; Nasser S; Inci G; Friedlander M
Gynecol Oncol; 2019 Oct; 155(1):126-134. PubMed ID: 31416612
[TBL] [Abstract][Full Text] [Related]
12. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.
King MT; Stockler MR; Butow P; O'Connell R; Voysey M; Oza AM; Gillies K; Donovan HS; Mercieca-Bebber R; Martyn J; Sjoquist K; Friedlander ML
Int J Gynecol Cancer; 2014 Jun; 24(5):865-73. PubMed ID: 24844220
[TBL] [Abstract][Full Text] [Related]
13. Sexual activity and functioning in ovarian cancer survivors: an internet-based evaluation.
Hopkins TG; Stavraka C; Gabra H; Fallowfield L; Hood C; Blagden S
Climacteric; 2015 Feb; 18(1):94-8. PubMed ID: 25029389
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum.
Frey MK; Ellis AE; Koontz LM; Shyne S; Klingenberg B; Fields JC; Chern JY; Blank SV
Gynecol Oncol; 2017 Aug; 146(2):386-391. PubMed ID: 28602549
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.
Rauh-Hain JA; Foley OW; Winograd D; Andrade C; Clark RM; Vargas RJ; Hinchcliff EM; Esselen KM; Horowitz NS; del Carmen MG
Am J Obstet Gynecol; 2015 May; 212(5):600.e1-8. PubMed ID: 25514761
[TBL] [Abstract][Full Text] [Related]
16. Long-term adjustment of early-stage ovarian cancer survivors.
Matulonis UA; Kornblith A; Lee H; Bryan J; Gibson C; Wells C; Lee J; Sullivan L; Penson R
Int J Gynecol Cancer; 2008; 18(6):1183-93. PubMed ID: 18217977
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry.
Ezendam NP; Pijlman B; Bhugwandass C; Pruijt JF; Mols F; Vos MC; Pijnenborg JM; van de Poll-Franse LV
Gynecol Oncol; 2014 Dec; 135(3):510-7. PubMed ID: 25281491
[TBL] [Abstract][Full Text] [Related]
18. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.
Wahner Hendrickson AE; Hawthorne KM; Goode EL; Kalli KR; Goergen KM; Bakkum-Gamez JN; Cliby WA; Keeney GL; Visscher DW; Tarabishy Y; Oberg AL; Hartmann LC; Maurer MJ
Gynecol Oncol; 2015 Apr; 137(1):77-85. PubMed ID: 25620544
[TBL] [Abstract][Full Text] [Related]
19. Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach.
Lutgendorf SK; Shinn E; Carter J; Leighton S; Baggerly K; Guindani M; Fellman B; Matzo M; Slavich GM; Goodman MT; Tew W; Lester J; Moore KM; Karlan BY; Levine DA; Sood AK
Gynecol Oncol; 2017 Jul; 146(1):101-108. PubMed ID: 28527672
[TBL] [Abstract][Full Text] [Related]
20. A Comparative Analysis of Quality of Life in Women Diagnosed with Breast and Ovarian Cancer.
Słoniewski R; Dąbrowska-Bender M; Religioni U; Fronczak A; Staniszewska A; Duda-Zalewska A; Milewska M; Kędzierska M; Matkowski RA; Dykowska G; Słoniewska A; Kupiecka A
Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
